USA: NOTIFYING FDA OF A PERMANENT DISCONTINUANCE OR INTERRUPTION IN MANUFACTURING OF A DEVICE UNDER SECTION 506J - DECEMBER/JANUARY 2024
- 2023-12-26 02:01:02
FDA is issuing a guidance in relation to Section 506J of Federal Food, Drug, and Cosmetic Act. In which manufacturers are required to promptly notify the FDA, whether during or prior to a Public Health Emergency (PHE), of any permanent discontinuance or interruption in the production of specific devices.
了解更多